Related Experiment Videos
Pentoxifylline for intermittent claudication. A critical review
1Postgraduate Medical School, University of Exeter, England.
Angiology
|May 1, 1994
Summary
Pentoxifylline is a well-researched oral medication proven to significantly increase walking distance for individuals with intermittent claudication. While effective, the clinical relevance of symptomatic improvement may vary individually.
Area of Science:
- Pharmacology
- Vascular Medicine
- Clinical Trials
Background:
- Pentoxifylline is a widely studied oral medication.
- It is frequently prescribed for intermittent claudication.
- Twenty years of research have established its presence in the medical field.
Purpose of the Study:
- To synthesize findings from placebo-controlled trials on pentoxifylline for intermittent claudication.
- To evaluate the efficacy of pentoxifylline in improving walking distance.
- To identify limitations in existing research.
Main Methods:
- Systematic review of seventeen placebo-controlled trials.
- Analysis of studies investigating pentoxifylline's effect on walking distance.
- Assessment of scientific rigor and potential flaws in trial methodologies.
Main Results:
- The majority of trials demonstrated a statistically significant prolongation of walking distance with pentoxifylline.
- Consistent evidence supports pentoxifylline's ability to enhance physical capacity in patients.
- Identified methodological limitations across studies.
Conclusions:
- Pentoxifylline effectively prolongs walking distance in patients suffering from intermittent claudication.
- Clinical relevance of symptomatic improvement requires individualized patient assessment.
- Further research may be needed to address identified study limitations.